alpramil 12 mg/30 mg filmomhulde tabletten voor katten met een gewicht van minimaal 3 kg
alfasan nederland b.v. - milbemycine oxime; praziquantel - filmomhulde tablet - milbemycine oxime 12 mg/stuk; praziquantel 30 mg/stuk, - milbemycin oxime, combinations - katten
alpramil 16 mg/40 mg filmomhulde tabletten voor katten met een gewicht van minimaal 4 kg
alfasan nederland b.v. - milbemycine oxime; praziquantel - filmomhulde tablet - milbemycine oxime 16 mg/stuk; praziquantel 40 mg/stuk, - milbemycin oxime, combinations - katten
alpramil 4 mg/10 mg filmomhulde tabletten voor katten met een gewicht van minimaal 0,5 kg
alfasan nederland b.v. - milbemycine oxime; praziquantel - filmomhulde tablet - milbemycine oxime 4 mg/stuk; praziquantel 10 mg/stuk, - milbemycin oxime, combinations - katten
trifexis™ (spinosad + milbemycin oxime) chewable tablets
elanco us inc, - spinosad (unii: xpa88eap6v) (spinosad - unii:xpa88eap6v), milbemycin oxime (unii: 0502pun0gt) (milbemycin oxime - unii:0502pun0gt) - spinosad 140 mg - trifexis is indicated for the prevention of heartworm disease (dirofilaria immitis ). trifexis kills fleas and is indicated for the prevention and treatment of flea infestations (ctenocephalides felis ), and the treatment and control of adult hookworm (ancylostoma caninum ), adult roundworm (toxocara canis and toxascaris leonina ) and adult whipworm (trichuris vulpis ) infections in dogs and puppies 8 weeks of age or older and 5 pounds of body weight or greater. there are no known contraindications to the use of trifexis.
trifexis (spinosad + milbemycin oxime) chewable tablets for dogs 9.1 - 18kg
elanco australasia pty ltd - spinosad manufacturing concentrate; milbemycin oxime - oral tablet - spinosad manufacturing concentrate ungrouped active 560.0 mg/tb; milbemycin oxime antibiotic active 9.3 mg/tb - v15c + v15f vet small ani
trifexis (spinosad + milbemycin oxime) chewable tablets for dogs 4.6 - 9kg
elanco australasia pty ltd - spinosad manufacturing concentrate; milbemycin oxime - oral tablet - spinosad manufacturing concentrate ungrouped active 270.0 mg/tb; milbemycin oxime antibiotic active 4.5 mg/tb - v15c + v15f vet small ani
trifexis (spinosad + milbemycin oxime) chewable tablets for dogs 2.3 - 4.5kg
elanco australasia pty ltd - spinosad manufacturing concentrate; milbemycin oxime - oral tablet - spinosad manufacturing concentrate ungrouped active 140.0 mg/tb; milbemycin oxime antibiotic active 2.3 mg/tb - v15c + v15f vet small ani
trifexis (spinosad + milbemycin oxime) chewable tablets for dogs 27.1 - 54 kg
elanco australasia pty ltd - spinosad manufacturing concentrate; milbemycin oxime - oral tablet - spinosad manufacturing concentrate ungrouped active 1620.0 mg/tb; milbemycin oxime antibiotic active 27.0 mg/tb - v15c + v15f vet small ani
trifexis (spinosad + milbemycin oxime) chewable tablets for dogs 18.1 - 27 kg
elanco australasia pty ltd - spinosad manufacturing concentrate; milbemycin oxime - oral tablet - spinosad manufacturing concentrate ungrouped active 810.0 mg/tb; milbemycin oxime antibiotic active 13.5 mg/tb - v15c + v15f vet small ani
comfortis plus (spinosad + milbemycin oxime) chewable tablets for dogs 18.1-27kg
elanco malaysia sdn bhd - milbemycin oxime; spinosad -